CLOV vs KAPA · rev $1.37B vs $18.8M cap
Clover Health Investments Corp (CLOV) versus Kairos Pharma, Ltd. (KAPA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Kairos Pharma, Ltd. (KAPA) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
KAPA does not have a complete income-statement cache yet.
CLOV currently screens at market cap $1.55B. KAPA currently screens at market cap $18.8M.
Not investment advice. Open the CLOV and KAPA stock pages for the full models.
Not investment advice.